Telik (TELK) Resumes Trading, Up 73%
Get Alerts TELK Hot Sheet
Join SI Premium – FREE
Telik Inc. (NASDAQ: TELK) has resumed trading following the volatility trading halt and is now up 73% to $2.51. The company was granted orphan drug status for Telintra for myelodysplastic syndrome.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD)
- NYSE to Commence Delisting Proceedings Against Fisker Inc. (FSR)
- Shockwave Medical (SWAV) Halted on Volatility Following Takeover Report
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!